[Tricyclic antidepressant, tetracyclic antidepressant].
Koyama
T
T
Department of Psychiatry, Hokkaido University Graduate School of Medicine.
Inoue
T
T
D018759:Adrenergic Uptake Inhibitors; D000317:Adrenergic alpha-Antagonists; D018687:Antidepressive Agents, Second-Generation / Q000009:adverse effects / Q000737:chemistry / Q000494:pharmacology*; D000929:Antidepressive Agents, Tricyclic / Q000009:adverse effects / Q000737:chemistry / Q000494:pharmacology*; D006801:Humans; D007099:Imipramine / Q000009:adverse effects / Q000737:chemistry / Q000494:pharmacology; D008376:Maprotiline / Q000009:adverse effects / Q000737:chemistry / Q000494:pharmacology; D017367:Selective Serotonin Reuptake Inhibitors
D018759:Adrenergic Uptake Inhibitors; D000317:Adrenergic alpha-Antagonists; D018687:Antidepressive Agents, Second-Generation; D000929:Antidepressive Agents, Tricyclic; D007099:Imipramine; D008376:Maprotiline; D017367:Selective Serotonin Reuptake Inhibitors